Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
Open Access
- 19 January 2010
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (4) , 754-756
- https://doi.org/10.2337/dc09-1938
Abstract
OBJECTIVE: To compare the sensitivity and specificity of luciferase immunoprecipitation (LIPS) with radioimmunoprecipitation (RIP) for the measurement of autoantibodies to the type 1 diabetes autoantigens glutamic acid decarboxylase 65 (GAD65) and insulinoma-associated protein (IA)-2β. RESEARCH DESIGN AND METHODS: Sera from 49 type 1 diabetic patients and 100 nondiabetic control subjects from Diabetes Antibody Standardization Program 2007 were used to screen for autoantibodies to GAD65. An additional 200 type 1 diabetic patients and 200 nondiabetic control subjects were used to validate the GAD65 results and screen for autoantibodies to IA-2β. RESULTS: LIPS showed equal sensitivity and specificity to RIP for detecting autoantibodies to GAD65 and IA-2β. Receiver-operating characteristic analysis revealed that the detection of autoantibodies to GAD65 and IA-2β by LIPS and RIP were not statistically different. CONCLUSIONS: The LIPS assay does not require the use of radioisotopes or in vitro transcription/translation and is a practical alternative at the clinical level for the RIP assay.Keywords
This publication has 11 references indexed in Scilit:
- A Report on the International Transglutaminase Autoantibody Workshop for Celiac DiseaseAmerican Journal of Gastroenterology, 2008
- A New Luminescence Assay for Autoantibodies to Mammalian Cell–Prepared Insulinoma-Associated Protein 2Diabetes Care, 2008
- Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2Diabetologia, 2008
- Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigensClinical Immunology, 2008
- Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relativesDiabetologia, 2008
- New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action.2007
- New Predictors of DiseaseScientific American, 2007
- Autoimmune type 1 diabetes: resolved and unresolved issuesJournal of Clinical Investigation, 2001
- Autoimmune type 1 diabetes: resolved and unresolved issuesJournal of Clinical Investigation, 2001
- Previous Exposure to Measles, Mumps, and Rubella—but Not Vaccination During Adolescence—Correlates to the Prevalence of Pancreatic and Thyroid AutoantibodiesPediatrics, 1999